Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$59,991,980
in 20 filings, $60.0M under 10b5-1 plans

Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 82 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-08 ANDERSON ELIZABETH M Director Grant or award +5,200 15,825
2023-06-08 ANDERSON ELIZABETH M Director Grant or award · Stock Option (Right to Buy) +18,400 18,400
2023-06-08 SCHMIDT ERIC THOMAS Director Grant or award +5,200 21,251
2023-06-08 SCHMIDT ERIC THOMAS Director Grant or award · Stock Option (Right to Buy) +18,400 18,400
2023-06-08 Patel Sushil Director Grant or award +5,200 15,700
2023-06-08 Patel Sushil Director Grant or award · Stock Option (Right to Buy) +18,400 18,400
2023-06-08 Kim Lorence H. Director Grant or award +5,200 65,700
2023-06-08 Kim Lorence H. Director Grant or award · Stock Option (Right to Buy) +18,400 18,400
2023-03-17 Horn Margaret A Sale −1,230 $21.78 $27K 100,062
2023-03-17 Anders Jack Chief Financial Officer Sale −665 $21.78 $14K 55,233
2023-03-17 Kelsey Stephen Michael Sale −1,230 $21.78 $27K 326,369
2023-03-17 Wang Xiaolin Sale −714 $21.78 $16K 58,813
2023-03-10 Schroeder Thilo Director Purchase +93,800 $20.43 $1.9M 1,546,934
2023-03-10 Schroeder Thilo Director Purchase +6,200 $20.85 $129K 1,553,134
2023-03-07 Schroeder Thilo Director Purchase +231,819 $22.00 $5.1M 1,453,134
2023-03-07 Schroeder Thilo Director Purchase +318,181 $22.00 $7.0M 618,181
2023-03-01 Anders Jack Chief Financial Officer Grant or award +26,600 55,898
2023-03-01 Anders Jack Chief Financial Officer Grant or award · Stock Option (Right to Buy) +93,100 93,100
2023-03-01 Wang Xiaolin Grant or award +29,000 59,527
2023-03-01 Wang Xiaolin Grant or award · Stock Option (Right to Buy) +101,500 101,500

Page 33 of 39 · 775 trades